SpaceQ Article: Canadian Space Agency Funds Health Technologies for Deep-Space Exploration
The Canadian Space Agency announced it has awarded 13 contracts to the health and biomedical communities as part of their health technologies initiative for for Deep-Space Exploration.
Calian Ltd. – Development of a DNA-Based Dosimeter (Ottawa, Ontario $99,672)
Calian aims to further explore the capability of a biologically-based gel dosimeter to measure the mixed-radiation field in deep space.
As deoxyribonucleic acid (DNA) provides crucial understandings to the biological effects of radiation, the proposed solution offers a device in which tissue-equivalent double-strand DNA breaks are used to estimate the quantity of radiation absorbed by crew members. The DNA-based dosimeter will also be able to qualify the type of radiation field by comparing single strand breaks with double strand breaks under various space radiation fields.